Cell-mediated immunological responsiveness in mice decomplemented with cobra venom factor

Area of Science:

• Immunology
• Complement System
• T cell immunology

Background:

• Cobra factor (CoF), a C3-activating protein from cobra venom, has been suggested to modulate immune responses.
• Previous studies indicated CoF administration could prolong skin allograft survival and inhibit delayed hypersensitivity reactions.

Purpose of the Study:

• To investigate the effect of in vivo complement depletion using cobra factor (CoF) on T cell-mediated immune responses.
• To clarify whether observed immunomodulatory effects of CoF are due to complement depletion or impurities in the venom preparation.

Main Methods:

• In vitro lymphocyte proliferation assays stimulated by PHA, LPS, and allogeneic cells.
• Assessment of cytotoxic T lymphocyte generation against allogeneic target cells.
• Evaluation of host-versus-graft (HVG) reactivity and skin allograft survival in vivo.
• Comparison of effects using commercially available versus purified CoF.

Main Results:

• In vivo CoF administration did not suppress in vitro lymphocyte responses to mitogens or allogeneic cells.
• CoF did not affect the generation of cytotoxic T cells.
• Commercially available CoF inhibited HVG reactivity, but purified CoF did not.
• Purified CoF failed to prolong skin allograft survival.

Conclusions:

• In vivo complement depletion via CoF does not interfere with T cell-mediated immune responses.
• Observed immunosuppressive effects in prior studies are likely attributable to impurities in CoF preparations, not complement depletion itself.
• This research clarifies the role of complement in T cell immunity and the specific effects of CoF.